Retatrutide (LY3437943) is a much more complex moleculea peptide that functions as a triple hormone receptor agonist
Statements estimating treatment duration and the number of treatments required are based on the typical experience of our patients, however, individual experiences may vary
Reason #4: We dont know enough yet This is perhaps the most honest reason: the absence of data isnt the same as data showing safety
If retatrutide succeeds across multiple indications, it will force a fundamental rethinking of how we value therapies
BOOK A CONSULTATION WITH AN EXPERIENCED AUSTRALIAN DOCTOR TODAY TO DISCUSS YOUR HAIR AND SCALP CONCERNS: CLICK HERE REFERENCES: Hamblin PS, Earnest A, Russell AW, Talic S, Zomer E, Zoungas S
Retatrutide remains experimental and has not yet been approved by the U.S Food and Drug Administration